HKD 0.09
(-3.37%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 82 Thousand CNY | 100.08% |
2022 | -100.56 Million CNY | 52.79% |
2021 | -213 Million CNY | 58.98% |
2020 | -519.29 Million CNY | 7.07% |
2019 | -558.79 Million CNY | -60.12% |
2018 | -348.99 Million CNY | -16.1% |
2017 | -300.58 Million CNY | -276.33% |
2016 | -79.87 Million CNY | -182.19% |
2015 | 97.18 Million CNY | -85.63% |
2014 | 676.33 Million CNY | 30.19% |
2013 | 519.48 Million CNY | 72.15% |
2012 | 301.75 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q2 | -20.99 Million CNY | 0.0% |
2023 Q4 | 21.07 Million CNY | 0.0% |
2022 Q2 | -31.36 Million CNY | 0.0% |
2022 FY | -100.56 Million CNY | 52.79% |
2022 Q4 | -55.02 Million CNY | 0.0% |
2021 FY | -213 Million CNY | 58.98% |
2021 Q4 | -45.87 Million CNY | 0.0% |
2021 Q2 | -123.85 Million CNY | 0.0% |
2020 Q4 | -194.28 Million CNY | 0.0% |
2020 Q2 | -249.16 Million CNY | 0.0% |
2020 FY | -519.29 Million CNY | 7.07% |
2019 FY | -558.79 Million CNY | -60.12% |
2019 Q2 | -180.39 Million CNY | 0.0% |
2019 Q4 | -322.23 Million CNY | 0.0% |
2018 Q2 | -123.52 Million CNY | 0.0% |
2018 FY | -348.99 Million CNY | -16.1% |
2018 Q4 | -176.28 Million CNY | 0.0% |
2017 FY | -300.58 Million CNY | -276.33% |
2017 Q2 | -184.89 Million CNY | 0.0% |
2017 Q4 | -115.69 Million CNY | 0.0% |
2016 FY | -79.87 Million CNY | -182.19% |
2016 Q2 | -57.48 Million CNY | 0.0% |
2016 Q4 | -85.6 Million CNY | 0.0% |
2015 FY | 97.18 Million CNY | -85.63% |
2015 Q4 | 115.34 Million CNY | 0.0% |
2015 Q2 | -84.75 Million CNY | 0.0% |
2014 FY | 676.33 Million CNY | 30.19% |
2014 Q4 | 331.03 Million CNY | 0.0% |
2014 Q2 | 350.27 Million CNY | 0.0% |
2013 Q2 | 305.14 Million CNY | 149.16% |
2013 Q4 | 325.77 Million CNY | 98.34% |
2013 FY | 519.48 Million CNY | 72.15% |
2013 Q3 | 164.24 Million CNY | -46.17% |
2013 Q1 | 122.47 Million CNY | -42.92% |
2012 FY | 301.75 Million CNY | 0.0% |
2012 Q4 | 214.57 Million CNY | 75.2% |
2012 Q3 | 122.47 Million CNY | 0.0% |
2012 Q2 | 122.47 Million CNY | 67.61% |
2012 Q1 | 73.06 Million CNY | 0.0% |
2011 Q2 | 73.06 Million CNY | 0.0% |
2011 Q3 | 73.06 Million CNY | 0.0% |
2011 Q4 | 73.06 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
China Healthwise Holdings Limited | -112.57 Million HKD | 100.073% |
Tycoon Group Holdings Limited | 336.55 Million HKD | 99.976% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million HKD | 99.987% |